The Institute of Bioorganic Chemistry offers consumers a technology for the synthesis of artificial genes under a commercial agreement with technical assistance and is looking for partners to conclude a recearch cooperation agreement.

The technology makes it possible to obtain synthetic genes (double-stranded DNA of a given sequence), including those built into plasmid vectors. To illustrate the capabilities of the technology, a demo layout has been developed.

Applications: biotechnology, biopharmaceutics, scientific research.

Included in the Catalog of exhibits (TOP DEVELOPMENTS by exposition clusters) of the exhibition of scientific and technological achievements "Intellectual Belarus 2023".

Innovative technology for obtaining synthetic genes.

Protected by a patent of the Republic of Belarus.

Main activities:
- fundamental and applied research in the field of chemistry, structure and function of biopolymers and low molecular weight bioregulators, including proteins, nucleic acids and their components, phospholipids, steroids, prostaglandins, brassinosteroids, ecdysteroids;
- development and pilot production of immunochemical and molecular biological reagent kits for medical and veterinary diagnostics;
- development and production of pharmaceutical substances, hormonal preparations and biospecific hemosorbents;
- development of technologies for the production and use of growth stimulants and plant protection products;
- experimental and clinical pharmacology, pharmacy and drug technology, toxicology, human and animal biochemistry, biomedical and pharmaceutical chemistry;
- preclinical, bioequivalent and pharmaceutical trials.

The Institute of Bioorganic Chemistry successfully develops international relations in the main areas of its research. Currently, the Institute conducts joint research with scientific institutes of the CIS countries, Germany, USA, Canada, Sweden, Finland, Denmark, Holland, Vietnam and other countries.

Consumers interested in purchasing artificial gene synthesis technology under a commercial agreement with technical assistance.

Partners interested in improving of technology for the synthesis of artificial genes under a research cooperation agreement.